Sanjay Girdhari Asrani
· Professor of OphthalmologyDuke University · Ophthalmology
Active 1994–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
Research topics
- Medicine
- Ophthalmology
- Optometry
- Internal medicine
- Environmental health
- Surgery
- Anesthesia
- Pathology
- Dermatology
Selected publications
Advances in Therapy · 2020 · 88 citations
1st authorCorrespondingINTRODUCTION: New open-angle glaucoma (OAG) and ocular hypertension (OHT) therapies that reduce treatment burden and improve outcomes relative to currently available agents are needed. Netarsudil, a novel Rho kinase inhibitor approved by the US Food and Drug Administration, reduces intraocular pressure (IOP) by increasing trabecular outflow. Two phase 3 superiority studies compared a fixed-dose combination (FDC) of netarsudil and the prostaglandin latanoprost with each active component for IOP-l…
American Journal of Ophthalmology · 2019-06-21 · 84 citations
article1st authorCorrespondingAmerican Journal of Ophthalmology · 2020 · 81 citations
Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case Series
American Journal of Ophthalmology · 2020 · 57 citations
American Journal of Ophthalmology · 2020-08-17 · 28 citations
articleSenior author
Recent grants
Frequent coauthors
- 74 shared
Sandra S. Stinnett
Duke University
- 63 shared
Paul P. Lee
Wayne State University
- 62 shared
R. Rand Allingham
- 60 shared
Leon W. Herndon
Duke University
- 57 shared
Pratap Challa
- 53 shared
R. Zeimer
- 50 shared
David L. Epstein
- 49 shared
Julia Song
Southern California Eye Institute
Similar researchers at Duke University
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Sanjay Girdhari Asrani
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
